These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 23972066)
1. Role of the vitamin K epoxide reductase complex subunit 1 (VKORC1) -1639G>A gene polymorphism in patients with retinal vein occlusion. Weger M; Steinbrugger I; Renner W; Pöschl EM; Brockmann T; Rabensteiner DF; El-Shabrawi Y; Haas A Curr Eye Res; 2013 Dec; 38(12):1278-82. PubMed ID: 23972066 [TBL] [Abstract][Full Text] [Related]
2. Predictive value of the vitamin K epoxide reductase complex subunit 1 G-1639A and C1173T single nucleotide polymorphisms in retinal vein occlusion. Ortak H; Söğüt E; Demir H; Ardagil A; Benli I; Sahin S Clin Exp Ophthalmol; 2012; 40(7):743-8. PubMed ID: 22394334 [TBL] [Abstract][Full Text] [Related]
3. [Retinal vascular occlusion and polymorphisms in genes coding for components of vitamin K cycle]. Kakhktsyan SS; Moshetova LK; Turkina KI; Sychev DA Vestn Oftalmol; 2016; 132(4):94-97. PubMed ID: 28635929 [TBL] [Abstract][Full Text] [Related]
4. Association between Vitamin K Epoxide Reductase (VKORC1) -1639G>A Polymorphism and Osteoporosis in Postmenopausal Women. Kutluturk F; Inanir A; Rustemoglu A; Kaya SU; Demir AK; Dursun G; Yigit S Endocr Metab Immune Disord Drug Targets; 2018; 18(3):281-286. PubMed ID: 29437025 [TBL] [Abstract][Full Text] [Related]
5. Susceptiveness of Vitamin K epOxide Reductase Complex Subunit 1 Gene Polymorphism in Essential Hypertension. Turgut Cosan D; Yazıcı HU; Colak E; Soyocak A; Degirmenci I; Kurt H; Birdane A; Colak E; Gunes HV Genet Test Mol Biomarkers; 2017 May; 21(5):292-297. PubMed ID: 28281786 [TBL] [Abstract][Full Text] [Related]
6. G-1639A but Not C1173T Dubovyk YI; Harbuzova VY; Ataman AV Biomed Res Int; 2016; 2016():1298198. PubMed ID: 27703968 [TBL] [Abstract][Full Text] [Related]
7. Association of VKORC1-1639G>A polymorphism with susceptibility to ossification of the posterior longitudinal ligament of the spine: a Korean study. Chin DK; Han IB; Ropper AE; Jeon YJ; Kim DH; Kim YS; Park Y; Teng YD; Kim NK; Kuh SU Acta Neurochir (Wien); 2013 Oct; 155(10):1937-42. PubMed ID: 23732872 [TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms associated with the prevalence of retinal vein occlusion in a Greek population. Christodoulou A; Bagli E; Gazouli M; Moschos MM; Kitsos G Int Ophthalmol; 2019 Nov; 39(11):2637-2648. PubMed ID: 31065901 [TBL] [Abstract][Full Text] [Related]
9. Vitamin K epoxide reductase (VKORC1) gene mutations in osteoporosis: A pilot study. Holzer G; Grasse AV; Zehetmayer S; Bencur P; Bieglmayer C; Mannhalter C Transl Res; 2010 Jul; 156(1):37-44. PubMed ID: 20621035 [TBL] [Abstract][Full Text] [Related]
10. The c.-1639G>A polymorphism of the VKORC1 gene in Serbian population: retrospective study of the variability in response to oral anticoagulant therapy. Kovac MK; Maslac AR; Rakicevic LB; Radojkovic DP Blood Coagul Fibrinolysis; 2010 Sep; 21(6):558-63. PubMed ID: 20581661 [TBL] [Abstract][Full Text] [Related]
11. Two enzymes catalyze vitamin K 2,3-epoxide reductase activity in mouse: VKORC1 is highly expressed in exocrine tissues while VKORC1L1 is highly expressed in brain. Caspers M; Czogalla KJ; Liphardt K; Müller J; Westhofen P; Watzka M; Oldenburg J Thromb Res; 2015 May; 135(5):977-83. PubMed ID: 25747820 [TBL] [Abstract][Full Text] [Related]
12. Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients. Mrad M; Fekih-Mrissa N; Wathek C; Rannen R; Gabsi S; Gritli N J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1592-8. PubMed ID: 24630828 [TBL] [Abstract][Full Text] [Related]
13. Association study of high-frequency variants of Fernández-Vega B; Álvarez L; García M; Artime E; González Fernández A; Fernández-Vega C; Nicieza J; Vega JA; González-Iglesias H Ophthalmic Genet; 2019 Aug; 40(4):342-349. PubMed ID: 31418317 [No Abstract] [Full Text] [Related]
14. [Vitamin K epoxide reductase: Fresh blood for oral anticoagulant therapies]. Loriot MA; Beaune P Rev Med Interne; 2006 Dec; 27(12):979-82. PubMed ID: 17070618 [TBL] [Abstract][Full Text] [Related]
15. Stromal Cell-Derived Factor 1 Polymorphism in Retinal Vein Occlusion. Szigeti A; Ecsedy M; Schneider M; Lénárt L; Lesch B; Nagy ZZ; Fekete A; Récsán Z PLoS One; 2016; 11(11):e0166544. PubMed ID: 27832196 [TBL] [Abstract][Full Text] [Related]
16. Vitamin K epoxide reductase complex 1 (VKORC1) gene polymorphisms in population of Eastern Croatia. Mandić D; Mandić S; Horvat V; Samardzija M; Samardzija M Coll Antropol; 2013 Dec; 37(4):1321-6. PubMed ID: 24611351 [TBL] [Abstract][Full Text] [Related]
17. Sequence variation in vitamin K epoxide reductase gene is associated with survival and progressive coronary calcification in chronic kidney disease. Holden RM; Booth SL; Tuttle A; James PD; Morton AR; Hopman WM; Nolan RL; Garland JS Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1591-6. PubMed ID: 24855061 [TBL] [Abstract][Full Text] [Related]
18. Influence of proton pump inhibitors and VKORC1 mutations on CYP2C9-mediated dose requirements of vitamin K antagonist therapy: a pilot study. Brunner-Ziegler S; Jilma B; Magirr D; Sunder-Plassmann R; Giurgea GA; Hammer A; Margeta C; Brunner M; Koppensteiner R; Mannhalter C Br J Haematol; 2014 Nov; 167(4):547-53. PubMed ID: 25142093 [TBL] [Abstract][Full Text] [Related]
19. Influence of VKORC1 gene polymorphisms on the effect of oral vitamin K supplementation in over-anticoagulated patients. Zuchinali P; Souza GC; Aliti G; Botton MR; Goldraich L; Santos KG; Hutz MH; Bandinelli E; Rohde LE J Thromb Thrombolysis; 2014 Apr; 37(3):338-44. PubMed ID: 23771743 [TBL] [Abstract][Full Text] [Related]
20. Frequencies of VKORC1-1639G>A and rs397509427 in Patients on Warfarin and Healthy Syrian Subjects. Altawil Y; Youssef LA Cardiovasc Ther; 2023; 2023():8898922. PubMed ID: 38045109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]